Sep 15 2024

Rhode Island: August is a Record-Breaking Month for Legal Marijuana Sales

August marijuana sales in Rhode Island broke the previously monthly record.

In Rhode Island, there was $8.23 million worth of recreational marijuana sold in August, in addition to $2.01 million in sales made by medical marijuana patients, according to the Department of Business Regulations. The combined $10.25 million is a new monthly record for the state, which legalized marijuana in 2021. The previous monthly record was $10.20 million sold in December 2023.

The year-to-date total for marijuana sales is now approximately $79 million, spread across 2,142,155 different transactions. The average transaction amount was $36.83.
Continue reading

Sep 14 2024

Pakistan National Assembly Passes Bill to Regulate Marijuana for Industrial and Medicinal Use.

The Pakistan National Assembly has passed legislation to legalize and regulate the cultivation, manufacturing, and sale of marijuana and its derivatives for industrial and medical use.

“This legislation aims to establish a clear regulatory framework to generate government revenue through taxation and to promote the development of supply chain for industrial and medicinal cannabis”, states the objective section of the Cannabis Control and Regulatory Authority Act. “[This measure is designed to] ensure public health and safety by regulating the cultivation, extraction, refining, manufacturing and sale of cannabis and its derivatives in accordance with international obligations and best practices.”

In addition, the measure aims “to promote local development of Cannabis based medicinal and industrial products, export generation and attracting Foreign Direct Investing (FDI), undertake research, development, and capacity building initiatives in collaboration with international counterparts to promote the growth and development of the Cannabis industry in Pakistan.”
Continue reading

Sep 14 2024

Clinical Trial Finds Topical Hemp Seed Oil Comparable to Diclofenac Gel for Treating Osteoarthritis

According to a new study published in the journal Pain Management Nursing, hemp seed oil may help alleviate the pain associated with knee osteoarthritis (OA), a widespread and crippling condition, especially for the elderly.

The randomized, double-blind controlled trial aimed to determine if topical hemp seed oil could provide relief comparable to standard treatments like diclofenac gel.

The study involved 90 participants who were randomly divided into three groups. One group received hemp seed oil, the second used diclofenac gel, and the third applied a placebo. Participants applied the topical treatments daily for two months, with assessments conducted at the beginning of the study and after 4 and 8 weeks.
Continue reading

Sep 13 2024

Study: Cannabidiol (CBD) Shows Antiviral Effects Against SARS-CoV-2

A recent study published in the Journal of Cellular and Molecular Medicine has revealed that cannabidiol (CBD) may have antiviral properties against the SARS-CoV-2 virus, which causes COVID-19.

A 3D model of SARS-CoV-2 (photo credit: Georgia State University).

“The aim of this study was to determine the antiviral activity of cannabidiol (CBD) against SARS-CoV-2 infection”, states the study’s abstract. “CBD is the second most studied cannabinoid obtained from Cannabis plants. We investigated the potential use of CBD, which has so far proven to have a positive effect on different diseases, in the SARS-CoV-2 infection.”

To test this, in vivo studies were carried out using K18-hACE2 transgenic mice, a commonly used model for studying human viral infections, including COVID-19. To reveal the potential therapeutic effect of the CBD at “the histopathological and molecular level challenge experiments were performed.”
Continue reading

Sep 13 2024

New Jersey Lawmakers File Resolution Urging U.S. Congress to Deschedule Marijuana

New Jersey Assemblymember Michael Venezia (D) has introduced Assembly Resolution 153, which urges the U.S. Congress to deschedule marijuana, removing it as a controlled substance under the federal Controlled Substances Act (CSA).

(Photo credit: David Paul Morris/Bloomberg).

The resolution, co-sponsored by Representatives Gabriel Rodriguez (D), Carmen Morales (D), Verlina Reynolds-Jackson (D), and Annette Quijano (D), reflects growing support in New Jersey for federal cannabis reform.

Under the CSA, established in 1970, Schedule I substances are deemed to have a high potential for abuse, no accepted medical use, and lack safety for medical supervision. Marijuana remains classified as a Schedule I drug, despite its legalization for both medical and recreational use in New Jersey, and the growing body of research supporting its therapeutic benefits.
Continue reading

Sep 13 2024

Massachusetts Cannabis Control Commission Gets New Acting Chair

Massachusetts Treasurer Deborah Goldberg appointed Bruce Stebbins as acting chair of the Cannabis Control Commission (CCC) on Thursday, following the dismissal of former chair Shannon O’Brien earlier in the week.

Bruce Stebbins.

State Treasurer Deborah B. Goldberg appointed Bruce Stebbins to serve as Acting Chair of the Massachusetts Cannabis Control Commission (Commission) until a permanent Chair is selected.

“I am honored to accept the role of Acting Chair and look forward to working together with my colleagues and Commission staff on important policy initiatives in the coming months,” Stebbins said. “This is a crucial time for the state’s cannabis industry, which has grown in my four years as a Commissioner into a multi-billion-dollar, increasingly equitable marketplace. I take seriously our mission to oversee safe, accessible cannabis businesses and will continue supporting Massachusetts’ growth as a regional and national regulatory leader in this space.”
Continue reading

Sep 13 2024

FDA Asserts Authority to Remove Cannabis Products From the Market

An official with the Food and Drug Administration (FDA) says the agency has the power to remove cannabis-infused foods and beverages from the market.

FDA Deputy Commissioner for Human Foods James Jones.

During a House Energy & Commerce Subcommittee hearing, FDA Deputy Commissioner for Human Foods James Jones was questioned about the agency’s ability to address intoxicating cannabis products, including hemp derivatives that are legal under federal law (due to the passage of the 2018 farm bill that legalized hemp).

Jones explained that marijuana falls largely under the jurisdiction of the Drug Enforcement Administration (DEA), but under the Federal Food, Drug, and Cosmetic (FD&C) Act, the FDA can intervene when food or drink contains an unapproved “adulterant” like THC.
Continue reading

Sep 13 2024

Pennsylvania: Bipartisan Legislation to Legalize Recreational Marijuana Introduced With 17 Sponsors

Today, Pennsylvania State Representatives Aaron Kaufer (R-Luzerne) and Emily Kinkead (D-Allegheny), along with 15 cosponsors, introduced a comprehensive, bipartisan marijuana legalization bill in the House of Representatives.

Under the proposed law, those 21 and older would be allowed to possess and use up to 30 grams of marijuana for any use. Although medical marijuana patients would be allowed to grow up to five marijuana plants for personal use, recreational home grows would not be allowed.

The bipartisan measure would establish a system of licensed and regulated marijuana businesses, overseen by the Department of Agriculture.
Continue reading

Sep 12 2024

Study: Psilocybin May Ease Emotional Suffering for Terminal Brain Cancer Patients

A new case report published in the Journal of Palliative Medicine reveals the potential of psilocybin-assisted therapy (PAT) to provide relief for patients with terminal brain cancer facing existential distress.

Dried psilocybin mushrooms in a bowl.

Conducted at McGill University, the study follows a patient with stage 4 astrocytoma who, after conventional treatments failed, found significant psychological relief through PAT—without any negative side effects. Researchers claim this treatment approach could offer a transformative option for those struggling with the emotional toll of a terminal diagnosis.

Traditional therapies had been ineffective in alleviating the patient’s psychological suffering, notes the study. However, after receiving psilocybin-assisted therapy, the patient experienced significant relief from their existential distress without adverse effects. This is a notable finding, as patients with brain cancer have typically been excluded from similar studies.
Continue reading

Sep 12 2024

Lawsuit Filed to Block Nebraska Medical Marijuana Initiatives From November Ballot

A lawsuit has been filed in Lancaster County challenging two medical marijuana petitions set to appear on the November 5 ballot in Nebraska.

The suit, submitted just before the deadline for certifying the measures for the November ballot, claims the petitions are insufficient for several reasons.

John Kuehn, the plaintiff, stated in the lawsuit that he sought to review petition signatures from Nebraska Secretary of State Bob Evnen. While Evnen granted access to signatures from Douglas, Sarpy, and Lancaster counties, the lawsuit alleges that he excluded 20 other counties from review.
Continue reading